Telaglenastat Hydrochloride and Osimertinib in Treating Patients With EGFR-Mutated Stage IV Non-small Cell Lung Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
City of Hope Medical Center
National Cancer Institute (NCI)
Barbara Ann Karmanos Cancer Institute
NRG Oncology
University of Washington
National Cancer Institute (NCI)
Albert Einstein College of Medicine
Vanderbilt-Ingram Cancer Center
Barbara Ann Karmanos Cancer Institute
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
University of Washington
AstraZeneca